Product Highlight - Risperidone (Rosemide®)
20 Feb 2025
- Effective not only in acute setting of schizophrenia but in all stages of schizophrenia.¹
- Effective and well-tolerated in patients with chronic schizophrenia who do not respond to or cannot tolerate traditional antipsychotics.²
- Proven bioequivalent to the innovator brand³
References:
1. Raja M. Pharmacotherapy Update: Risperidone in the Treatment of Schizophrenia. Clinical Medicine Therapeutics. 2009;1. doi:10.4137/CMT.S1123.
2. Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Eap CB, Baumann P. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group. Am J Psychiatry. 1998 Apr;155(4):499-504.
3. Bioequivalence study of Risperidone 1 mg Orodispersible Tablets (Fasting) Protocol No: 850-18.
KUSUM HEALTHCARE PRIVATE LIMITED BRANCH OFFICE
Unit 2405 & 2406, 24/F The Orient Square, F. Ortigas Jr Rd,
Ortigas Ctr, San Antonio, Pasig City 1605
Phone: (+63-2) 8245 9048
